메뉴 건너뛰기




Volumn 25, Issue 11, 2015, Pages 3282-3294

Cost-utility analysis of nonalcoholic steatohepatitis screening

Author keywords

Cost effectiveness; Elastography; Fibrosis; Nonalcoholic fatty liver disease (NAFLD); Screening

Indexed keywords

CYTOKERATIN 18;

EID: 84943351607     PISSN: 09387994     EISSN: 14321084     Source Type: Journal    
DOI: 10.1007/s00330-015-3731-2     Document Type: Article
Times cited : (49)

References (108)
  • 1
    • 0038644536 scopus 로고    scopus 로고
    • Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference
    • PID: 12717402
    • Neuschwander-Tetri BA, Caldwell SH (2003) Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference. Hepatology 37:1202–1219
    • (2003) Hepatology , vol.37 , pp. 1202-1219
    • Neuschwander-Tetri, B.A.1    Caldwell, S.H.2
  • 2
    • 77952576769 scopus 로고    scopus 로고
    • Epidemiology of non-alcoholic fatty liver disease
    • PID: 20460905
    • Bellentani S, Scaglioni F, Marino M, Bedogni G (2010) Epidemiology of non-alcoholic fatty liver disease. Dig Dis 28:155–161
    • (2010) Dig Dis , vol.28 , pp. 155-161
    • Bellentani, S.1    Scaglioni, F.2    Marino, M.3    Bedogni, G.4
  • 3
    • 11144351102 scopus 로고    scopus 로고
    • The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies
    • PID: 15629518
    • Adams LA, Sanderson S, Lindor KD, Angulo P (2005) The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies. J Hepatol 42:132–138
    • (2005) J Hepatol , vol.42 , pp. 132-138
    • Adams, L.A.1    Sanderson, S.2    Lindor, K.D.3    Angulo, P.4
  • 4
    • 10644220306 scopus 로고    scopus 로고
    • Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity
    • PID: 15565570
    • Browning JD, Szczepaniak LS, Dobbins R et al (2004) Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology 40:1387–1395
    • (2004) Hepatology , vol.40 , pp. 1387-1395
    • Browning, J.D.1    Szczepaniak, L.S.2    Dobbins, R.3
  • 5
    • 33644547706 scopus 로고    scopus 로고
    • Nonalcoholic fatty liver disease: from steatosis to cirrhosis
    • COI: 1:CAS:528:DC%2BD28XhvVSktLo%3D, PID: 16447287
    • Farrell GC, Larter CZ (2006) Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology 43:S99–S112
    • (2006) Hepatology , vol.43 , pp. S99-S112
    • Farrell, G.C.1    Larter, C.Z.2
  • 6
    • 33750606061 scopus 로고    scopus 로고
    • Long-term follow-up of patients with NAFLD and elevated liver enzymes
    • COI: 1:CAS:528:DC%2BD28XhtFyqsrzN, PID: 17006923
    • Ekstedt M, Franzen LE, Mathiesen UL et al (2006) Long-term follow-up of patients with NAFLD and elevated liver enzymes. Hepatology 44:865–873
    • (2006) Hepatology , vol.44 , pp. 865-873
    • Ekstedt, M.1    Franzen, L.E.2    Mathiesen, U.L.3
  • 7
    • 77952730428 scopus 로고    scopus 로고
    • The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis
    • PID: 20209604
    • Ascha MS, Hanouneh IA, Lopez R, Tamimi TA, Feldstein AF, Zein NN (2010) The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis. Hepatology 51:1972–1978
    • (2010) Hepatology , vol.51 , pp. 1972-1978
    • Ascha, M.S.1    Hanouneh, I.A.2    Lopez, R.3    Tamimi, T.A.4    Feldstein, A.F.5    Zein, N.N.6
  • 8
    • 18544365700 scopus 로고    scopus 로고
    • Survival, liver failure, and hepatocellular carcinoma in obesity-related cryptogenic cirrhosis
    • PID: 12029634
    • Ratziu V, Bonyhay L, Di Martino V et al (2002) Survival, liver failure, and hepatocellular carcinoma in obesity-related cryptogenic cirrhosis. Hepatology 35:1485–1493
    • (2002) Hepatology , vol.35 , pp. 1485-1493
    • Ratziu, V.1    Bonyhay, L.2    Di Martino, V.3
  • 9
    • 77951456114 scopus 로고    scopus 로고
    • Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection
    • PID: 20432259
    • Starley BQ, Calcagno CJ, Harrison SA (2010) Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection. Hepatology 51:1820–1832
    • (2010) Hepatology , vol.51 , pp. 1820-1832
    • Starley, B.Q.1    Calcagno, C.J.2    Harrison, S.A.3
  • 10
  • 11
    • 77952529040 scopus 로고    scopus 로고
    • A position statement on NAFLD/NASH based on the EASL 2009 special conference
    • PID: 20494470
    • Ratziu V, Bellentani S, Cortez-Pinto H, Day C, Marchesini G (2010) A position statement on NAFLD/NASH based on the EASL 2009 special conference. J Hepatol 53:372–384
    • (2010) J Hepatol , vol.53 , pp. 372-384
    • Ratziu, V.1    Bellentani, S.2    Cortez-Pinto, H.3    Day, C.4    Marchesini, G.5
  • 12
    • 84861543083 scopus 로고    scopus 로고
    • The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
    • PID: 22488764
    • Chalasani N, Younossi Z, Lavine JE et al (2012) The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology 55:2005–2023
    • (2012) Hepatology , vol.55 , pp. 2005-2023
    • Chalasani, N.1    Younossi, Z.2    Lavine, J.E.3
  • 14
    • 80555136061 scopus 로고    scopus 로고
    • Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity
    • PID: 21039302
    • Musso G, Gambino R, Cassader M, Pagano G (2011) Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity. Ann Med 43:617–649
    • (2011) Ann Med , vol.43 , pp. 617-649
    • Musso, G.1    Gambino, R.2    Cassader, M.3    Pagano, G.4
  • 15
    • 34748845382 scopus 로고    scopus 로고
    • Ultrasound-based transient elastography for the detection of hepatic fibrosis: systematic review and meta-analysis
    • PID: 17916549
    • Talwalkar JA, Kurtz DM, Schoenleber SJ, West CP, Montori VM (2007) Ultrasound-based transient elastography for the detection of hepatic fibrosis: systematic review and meta-analysis. Clin Gastroenterol Hepatol 5:1214–1220
    • (2007) Clin Gastroenterol Hepatol , vol.5 , pp. 1214-1220
    • Talwalkar, J.A.1    Kurtz, D.M.2    Schoenleber, S.J.3    West, C.P.4    Montori, V.M.5
  • 16
    • 84876293750 scopus 로고    scopus 로고
    • Non-invasive diagnosis of non-alcoholic fatty liver disease. A critical appraisal
    • PID: 23183525
    • Machado MV, Cortez-Pinto H (2013) Non-invasive diagnosis of non-alcoholic fatty liver disease. A critical appraisal. J Hepatol 58:1007–1019
    • (2013) J Hepatol , vol.58 , pp. 1007-1019
    • Machado, M.V.1    Cortez-Pinto, H.2
  • 17
    • 77954025334 scopus 로고    scopus 로고
    • Biopsy and non-invasive methods for the diagnosis of liver fibrosis: does it take two to tango?
    • PID: 20581229
    • Castera L, Pinzani M (2010) Biopsy and non-invasive methods for the diagnosis of liver fibrosis: does it take two to tango? Gut 59:861–866
    • (2010) Gut , vol.59 , pp. 861-866
    • Castera, L.1    Pinzani, M.2
  • 18
    • 73449116035 scopus 로고    scopus 로고
    • Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis
    • COI: 1:CAS:528:DC%2BC3cXhsVCqtbg%3D, PID: 19827166
    • Promrat K, Kleiner DE, Niemeier HM et al (2010) Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis. Hepatology 51:121–129
    • (2010) Hepatology , vol.51 , pp. 121-129
    • Promrat, K.1    Kleiner, D.E.2    Niemeier, H.M.3
  • 19
    • 77951874018 scopus 로고    scopus 로고
    • Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis
    • COI: 1:CAS:528:DC%2BC3cXls1Oltr4%3D, PID: 20427778
    • Sanyal AJ, Chalasani N, Kowdley KV et al (2010) Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis. N Engl J Med 362:1675–1685
    • (2010) N Engl J Med , vol.362 , pp. 1675-1685
    • Sanyal, A.J.1    Chalasani, N.2    Kowdley, K.V.3
  • 20
    • 80055042241 scopus 로고    scopus 로고
    • The role of thiazolidinediones in non-alcoholic steatohepatitis—a systematic review and meta analysis
    • COI: 1:CAS:528:DC%2BC3MXhsV2mt7zE, PID: 21703200
    • Mahady SE, Webster AC, Walker S, Sanyal A, George J (2011) The role of thiazolidinediones in non-alcoholic steatohepatitis—a systematic review and meta analysis. J Hepatol 55:1383–1390
    • (2011) J Hepatol , vol.55 , pp. 1383-1390
    • Mahady, S.E.1    Webster, A.C.2    Walker, S.3    Sanyal, A.4    George, J.5
  • 21
    • 84870496528 scopus 로고    scopus 로고
    • Pioglitazone and vitamin E for nonalcoholic steatohepatitis: a cost utility analysis
    • COI: 1:CAS:528:DC%2BC38XhvVSmtb3M, PID: 22707355
    • Mahady SE, Wong G, Craig JC, George J (2012) Pioglitazone and vitamin E for nonalcoholic steatohepatitis: a cost utility analysis. Hepatology 56:2172–2179
    • (2012) Hepatology , vol.56 , pp. 2172-2179
    • Mahady, S.E.1    Wong, G.2    Craig, J.C.3    George, J.4
  • 22
    • 79955944811 scopus 로고    scopus 로고
    • Economic evaluation using decision analytical modelling: design, conduct, analysis, and reporting
    • PID: 21482590
    • Petrou S, Gray A (2011) Economic evaluation using decision analytical modelling: design, conduct, analysis, and reporting. BMJ 342:d1766
    • (2011) BMJ , vol.342 , pp. d1766
    • Petrou, S.1    Gray, A.2
  • 23
    • 58849090967 scopus 로고    scopus 로고
    • Hepatocellular carcinoma in patients with nonalcoholic steatohepatitis
    • PID: 19148800
    • Hashimoto E, Yatsuji S, Tobari M et al (2009) Hepatocellular carcinoma in patients with nonalcoholic steatohepatitis. J Gastroenterol 44(Suppl 19):89–95
    • (2009) J Gastroenterol , vol.44 , pp. 89-95
    • Hashimoto, E.1    Yatsuji, S.2    Tobari, M.3
  • 24
    • 79960029926 scopus 로고    scopus 로고
    • Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults
    • COI: 1:STN:280:DC%2BC3MnlsVamsg%3D%3D, PID: 21623852
    • Vernon G, Baranova A, Younossi ZM (2011) Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Aliment Pharmacol Ther 34:274–285
    • (2011) Aliment Pharmacol Ther , vol.34 , pp. 274-285
    • Vernon, G.1    Baranova, A.2    Younossi, Z.M.3
  • 25
    • 85017823782 scopus 로고    scopus 로고
    • Guidelines for the economic evaluation of health technologies: Canada (3rd edn)
    • Canadian Agency for Drugs and Technologies in Health (2006) Guidelines for the economic evaluation of health technologies: Canada (3rd edn). Ottawa 75
    • (2006) Ottawa 75
  • 26
    • 84863509606 scopus 로고    scopus 로고
    • Performance of magnetic resonance elastography and diffusion-weighted imaging for the staging of hepatic fibrosis: a meta-analysis
    • PID: 22278368
    • Wang QB, Zhu H, Liu HL, Zhang B (2012) Performance of magnetic resonance elastography and diffusion-weighted imaging for the staging of hepatic fibrosis: a meta-analysis. Hepatology 56:239–247
    • (2012) Hepatology , vol.56 , pp. 239-247
    • Wang, Q.B.1    Zhu, H.2    Liu, H.L.3    Zhang, B.4
  • 27
    • 84856968669 scopus 로고    scopus 로고
    • Acoustic radiation force impulse-imaging and transient elastography for non-invasive assessment of liver fibrosis and steatosis in NAFLD
    • PID: 22119555
    • Friedrich-Rust M, Romen D, Vermehren J et al (2011) Acoustic radiation force impulse-imaging and transient elastography for non-invasive assessment of liver fibrosis and steatosis in NAFLD. Eur J Radiol. doi:10.1016/j.ejrad.2011.10.029
    • (2011) Eur J Radiol
    • Friedrich-Rust, M.1    Romen, D.2    Vermehren, J.3
  • 28
    • 77957330216 scopus 로고    scopus 로고
    • Reduced mortality rates following elective percutaneous liver biopsies
    • PID: 20547160
    • West J, Card TR (2010) Reduced mortality rates following elective percutaneous liver biopsies. Gastroenterology 139:1230–1237
    • (2010) Gastroenterology , vol.139 , pp. 1230-1237
    • West, J.1    Card, T.R.2
  • 29
    • 84884419004 scopus 로고    scopus 로고
    • From NAFLD in clinical practice to answers from guidelines
    • PID: 23751754
    • Nascimbeni F, Pais R, Bellentani S et al (2013) From NAFLD in clinical practice to answers from guidelines. J Hepatol. doi:10.1016/j.jhep.2013.05.044
    • (2013) J Hepatol
    • Nascimbeni, F.1    Pais, R.2    Bellentani, S.3
  • 30
    • 57549107354 scopus 로고    scopus 로고
    • Pioglitazone versus vitamin E versus placebo for the treatment of non-diabetic patients with non-alcoholic steatohepatitis: PIVENS trial design
    • COI: 1:CAS:528:DC%2BD1cXhsFagsrbE, PID: 18804555
    • Chalasani NP, Sanyal AJ, Kowdley KV et al (2009) Pioglitazone versus vitamin E versus placebo for the treatment of non-diabetic patients with non-alcoholic steatohepatitis: PIVENS trial design. Contemp Clin Trials 30:88–96
    • (2009) Contemp Clin Trials , vol.30 , pp. 88-96
    • Chalasani, N.P.1    Sanyal, A.J.2    Kowdley, K.V.3
  • 31
    • 0028069441 scopus 로고
    • Determining transition probabilities: confusion and suggestions
    • COI: 1:STN:280:DyaK2c3gtlShtQ%3D%3D, PID: 8152357
    • Miller DK, Homan SM (1994) Determining transition probabilities: confusion and suggestions. Med Decis Making 14:52–58
    • (1994) Med Decis Making , vol.14 , pp. 52-58
    • Miller, D.K.1    Homan, S.M.2
  • 32
    • 84943361780 scopus 로고    scopus 로고
    • Canadian Medical Association. Canadian Provincial Billing Guide. Health Canada, Government of Canada. Accessed July 2013
    • Canadian Medical Association. Canadian Provincial Billing Guide. Health Canada, Government of Canada. Available at http://www.cma.ca/practicemanagement/medical-billing. Accessed July 2013
  • 33
    • 84947067702 scopus 로고    scopus 로고
    • A health technology assessment of transient elastography in liver disease
    • Unit UoCHTA (ed) Alberta Health Technologies Decision Process, Alberta
    • Steadman R, Leggett L, Lorenzetti D, Noseworthy T, Rose R, Sutherland L, Clement F (2012) A health technology assessment of transient elastography in liver disease. In: Unit UoCHTA (ed) Alberta Health Technologies Decision Process, Alberta
    • (2012) In
    • Steadman, R.1    Leggett, L.2    Lorenzetti, D.3    Noseworthy, T.4    Rose, R.5    Sutherland, L.6    Clement, F.7
  • 34
    • 84943366099 scopus 로고    scopus 로고
    • Barry MH (2004) Magnetic resonance imaging needs assessment.In: Health NSDo (ed) Nova Scotia pp 38
    • Barry MH (2004) Magnetic resonance imaging needs assessment.In: Health NSDo (ed) Nova Scotia pp 38
  • 35
    • 70449561873 scopus 로고    scopus 로고
    • CIHI, Ottawa
    • Canadian Institute for Health Information (2008) Medical imaging in Canada, 2007. CIHI, Ottawa
    • (2008) Medical imaging in Canada, 2007
  • 36
    • 84943357897 scopus 로고    scopus 로고
    • Peviva. M30 Apoptosense ELISA. Accessed July 2013
    • Peviva. M30 Apoptosense ELISA. Available at http://www.peviva.se/m30-apoptosense-elisa_us.aspx. Accessed July 2013
  • 38
    • 84884977723 scopus 로고    scopus 로고
    • Health care costs associated with hepatocellular carcinoma: a population-based study
    • PID: 23300063
    • Thein HH, Isaranuwatchai W, Campitelli MA et al (2013) Health care costs associated with hepatocellular carcinoma: a population-based study. Hepatology 58:1375–1384
    • (2013) Hepatology , vol.58 , pp. 1375-1384
    • Thein, H.H.1    Isaranuwatchai, W.2    Campitelli, M.A.3
  • 40
    • 84943357775 scopus 로고    scopus 로고
    • Bank of Canada Inflation Calculator. Accessed July 2013
    • Bank of Canada Inflation Calculator. Available at http://www.bankofcanada.ca/rates/related/inflation-calculator. Accessed July 2013
  • 41
    • 68949136754 scopus 로고    scopus 로고
    • Quality of life in adults with nonalcoholic fatty liver disease: baseline data from the nonalcoholic steatohepatitis clinical research network
    • PID: 19434741
    • David K, Kowdley KV, Unalp A et al (2009) Quality of life in adults with nonalcoholic fatty liver disease: baseline data from the nonalcoholic steatohepatitis clinical research network. Hepatology 49:1904–1912
    • (2009) Hepatology , vol.49 , pp. 1904-1912
    • David, K.1    Kowdley, K.V.2    Unalp, A.3
  • 42
    • 0035052537 scopus 로고    scopus 로고
    • Evaluating quality-adjusted life years: estimation of the health utility index (HUI2) from the SF-36
    • COI: 1:STN:280:DC%2BD3M3hslCgtg%3D%3D, PID: 11310943
    • Nichol MB, Sengupta N, Globe DR (2001) Evaluating quality-adjusted life years: estimation of the health utility index (HUI2) from the SF-36. Med Decis Making 21:105–112
    • (2001) Med Decis Making , vol.21 , pp. 105-112
    • Nichol, M.B.1    Sengupta, N.2    Globe, D.R.3
  • 43
    • 0037345686 scopus 로고    scopus 로고
    • Health-state utilities and quality of life in hepatitis C patients
    • PID: 12650799
    • Chong CA, Gulamhussein A, Heathcote EJ et al (2003) Health-state utilities and quality of life in hepatitis C patients. Am J Gastroenterol 98:630–638
    • (2003) Am J Gastroenterol , vol.98 , pp. 630-638
    • Chong, C.A.1    Gulamhussein, A.2    Heathcote, E.J.3
  • 44
    • 0035120575 scopus 로고    scopus 로고
    • Assessment of utilities and health-related quality of life in patients with chronic liver disease
    • COI: 1:STN:280:DC%2BD3M7ot12lsg%3D%3D, PID: 11232711
    • Younossi ZM, Boparai N, McCormick M, Price LL, Guyatt G (2001) Assessment of utilities and health-related quality of life in patients with chronic liver disease. Am J Gastroenterol 96:579–583
    • (2001) Am J Gastroenterol , vol.96 , pp. 579-583
    • Younossi, Z.M.1    Boparai, N.2    McCormick, M.3    Price, L.L.4    Guyatt, G.5
  • 45
    • 0036196936 scopus 로고    scopus 로고
    • Assessing health-related quality of life pre- and post-liver transplantation: a prospective multicenter study
    • PID: 11910572
    • Ratcliffe J, Longworth L, Young T et al (2002) Assessing health-related quality of life pre- and post-liver transplantation: a prospective multicenter study. Liver Transpl 8:263–270
    • (2002) Liver Transpl , vol.8 , pp. 263-270
    • Ratcliffe, J.1    Longworth, L.2    Young, T.3
  • 46
    • 47249161145 scopus 로고    scopus 로고
    • Health-state utilities in liver disease: a systematic review
    • PID: 18424560
    • McLernon DJ, Dillon J, Donnan PT (2008) Health-state utilities in liver disease: a systematic review. Med Decis Making 28:582–592
    • (2008) Med Decis Making , vol.28 , pp. 582-592
    • McLernon, D.J.1    Dillon, J.2    Donnan, P.T.3
  • 47
    • 77955147344 scopus 로고    scopus 로고
    • Nonalcoholic fatty liver disease: US-based acoustic radiation force impulse elastography
    • PID: 20529989
    • Yoneda M, Suzuki K, Kato S et al (2010) Nonalcoholic fatty liver disease: US-based acoustic radiation force impulse elastography. Radiology 256:640–647
    • (2010) Radiology , vol.256 , pp. 640-647
    • Yoneda, M.1    Suzuki, K.2    Kato, S.3
  • 48
    • 84881552256 scopus 로고    scopus 로고
    • Meta-analysis: ARFI elastography versus transient elastography for the evaluation of liver fibrosis
    • PID: 23859217
    • Bota S, Herkner H, Sporea I et al (2013) Meta-analysis: ARFI elastography versus transient elastography for the evaluation of liver fibrosis. Liver Int 33:1138–1147
    • (2013) Liver Int , vol.33 , pp. 1138-1147
    • Bota, S.1    Herkner, H.2    Sporea, I.3
  • 49
    • 77958154016 scopus 로고    scopus 로고
    • Controlled attenuation parameter (CAP): a novel VCTE guided ultrasonic attenuation measurement for the evaluation of hepatic steatosis: preliminary study and validation in a cohort of patients with chronic liver disease from various causes
    • PID: 20870345
    • Sasso M, Beaugrand M, de Ledinghen V et al (2010) Controlled attenuation parameter (CAP): a novel VCTE guided ultrasonic attenuation measurement for the evaluation of hepatic steatosis: preliminary study and validation in a cohort of patients with chronic liver disease from various causes. Ultrasound Med Biol 36:1825–1835
    • (2010) Ultrasound Med Biol , vol.36 , pp. 1825-1835
    • Sasso, M.1    Beaugrand, M.2    de Ledinghen, V.3
  • 50
    • 84856708238 scopus 로고    scopus 로고
    • The controlled attenuation parameter (CAP): a novel tool for the non-invasive evaluation of steatosis using Fibroscan
    • COI: 1:STN:280:DC%2BC383it1aitQ%3D%3D, PID: 21920839
    • Sasso M, Miette V, Sandrin L, Beaugrand M (2012) The controlled attenuation parameter (CAP): a novel tool for the non-invasive evaluation of steatosis using Fibroscan. Clin Res Hepatol Gastroenterol 36:13–20
    • (2012) Clin Res Hepatol Gastroenterol , vol.36 , pp. 13-20
    • Sasso, M.1    Miette, V.2    Sandrin, L.3    Beaugrand, M.4
  • 51
    • 84155188892 scopus 로고    scopus 로고
    • Feasibility and diagnostic performance of the FibroScan XL probe for liver stiffness measurement in overweight and obese patients
    • PID: 21898479
    • Myers RP, Pomier-Layrargues G, Kirsch R et al (2012) Feasibility and diagnostic performance of the FibroScan XL probe for liver stiffness measurement in overweight and obese patients. Hepatology 55:199–208
    • (2012) Hepatology , vol.55 , pp. 199-208
    • Myers, R.P.1    Pomier-Layrargues, G.2    Kirsch, R.3
  • 52
    • 77956015752 scopus 로고    scopus 로고
    • Feasibility of liver transient elastography with FibroScan using a new probe for obese patients
    • PID: 20492500
    • de Ledinghen V, Vergniol J, Foucher J, El-Hajbi F, Merrouche W, Rigalleau V (2010) Feasibility of liver transient elastography with FibroScan using a new probe for obese patients. Liver Int 30:1043–1048
    • (2010) Liver Int , vol.30 , pp. 1043-1048
    • de Ledinghen, V.1    Vergniol, J.2    Foucher, J.3    El-Hajbi, F.4    Merrouche, W.5    Rigalleau, V.6
  • 53
    • 84856968669 scopus 로고    scopus 로고
    • Acoustic radiation force impulse-imaging and transient elastography for non-invasive assessment of liver fibrosis and steatosis in NAFLD
    • PID: 22119555
    • Friedrich-Rust M, Romen D, Vermehren J et al (2012) Acoustic radiation force impulse-imaging and transient elastography for non-invasive assessment of liver fibrosis and steatosis in NAFLD. Eur J Radiol 81:e325–e331
    • (2012) Eur J Radiol , vol.81 , pp. e325-e331
    • Friedrich-Rust, M.1    Romen, D.2    Vermehren, J.3
  • 54
    • 84860389114 scopus 로고    scopus 로고
    • Noninvasive evaluation of hepatic fibrosis using acoustic radiation force-based shear stiffness in patients with nonalcoholic fatty liver disease
    • PID: 21256907
    • Palmeri ML, Wang MH, Rouze NC et al (2011) Noninvasive evaluation of hepatic fibrosis using acoustic radiation force-based shear stiffness in patients with nonalcoholic fatty liver disease. J Hepatol 55:666–672
    • (2011) J Hepatol , vol.55 , pp. 666-672
    • Palmeri, M.L.1    Wang, M.H.2    Rouze, N.C.3
  • 55
    • 84870374798 scopus 로고    scopus 로고
    • Detection of non-alcoholic steatohepatitis in patients with morbid obesity before bariatric surgery: preliminary evaluation with acoustic radiation force impulse imaging
    • COI: 1:STN:280:DC%2BC38nnsFeguw%3D%3D, PID: 22648049
    • Guzman-Aroca F, Frutos-Bernal MD, Bas A et al (2012) Detection of non-alcoholic steatohepatitis in patients with morbid obesity before bariatric surgery: preliminary evaluation with acoustic radiation force impulse imaging. Eur Radiol 22:2525–2532
    • (2012) Eur Radiol , vol.22 , pp. 2525-2532
    • Guzman-Aroca, F.1    Frutos-Bernal, M.D.2    Bas, A.3
  • 56
    • 84861912749 scopus 로고    scopus 로고
    • Preventing overdiagnosis: how to stop harming the healthy
    • PID: 22645185
    • Moynihan R, Doust J, Henry D (2012) Preventing overdiagnosis: how to stop harming the healthy. BMJ 344, e3502
    • (2012) BMJ , vol.344
    • Moynihan, R.1    Doust, J.2    Henry, D.3
  • 57
    • 70349770695 scopus 로고    scopus 로고
    • Epidemiology and natural history of non-alcoholic steatohepatitis
    • PID: 19818302
    • Argo CK, Caldwell SH (2009) Epidemiology and natural history of non-alcoholic steatohepatitis. Clin Liver Dis 13:511–531
    • (2009) Clin Liver Dis , vol.13 , pp. 511-531
    • Argo, C.K.1    Caldwell, S.H.2
  • 58
    • 79956011925 scopus 로고    scopus 로고
    • Progression from isolated steatosis to steatohepatitis and fibrosis in nonalcoholic fatty liver disease
    • PID: 21095517
    • Pais R, Pascale A, Fedchuck L, Charlotte F, Poynard T, Ratziu V (2010) Progression from isolated steatosis to steatohepatitis and fibrosis in nonalcoholic fatty liver disease. Gastroenterol Clin Biol. doi:10.1016/j.gcb.2010.06.004
    • (2010) Gastroenterol Clin Biol
    • Pais, R.1    Pascale, A.2    Fedchuck, L.3    Charlotte, F.4    Poynard, T.5    Ratziu, V.6
  • 59
    • 75449102165 scopus 로고    scopus 로고
    • Long-term mortality in nonalcoholic fatty liver disease: is liver histology of any prognostic significance?
    • PID: 20101746
    • Angulo P (2010) Long-term mortality in nonalcoholic fatty liver disease: is liver histology of any prognostic significance? Hepatology 51:373–375
    • (2010) Hepatology , vol.51 , pp. 373-375
    • Angulo, P.1
  • 60
    • 80053649814 scopus 로고    scopus 로고
    • Steatosis degree, measured by morphometry, is linked to other liver lesions and metabolic syndrome components in patients with NAFLD
    • COI: 1:CAS:528:DC%2BC3MXht1Ohs7zE, PID: 21904208
    • Boursier J, Chaigneau J, Roullier V et al (2011) Steatosis degree, measured by morphometry, is linked to other liver lesions and metabolic syndrome components in patients with NAFLD. Eur J Gastroenterol Hepatol 23:974–981
    • (2011) Eur J Gastroenterol Hepatol , vol.23 , pp. 974-981
    • Boursier, J.1    Chaigneau, J.2    Roullier, V.3
  • 61
    • 85027925485 scopus 로고    scopus 로고
    • Correlation between liver histology and novel magnetic resonance imaging in adult patients with non-alcoholic fatty liver disease—MRI accurately quantifies hepatic steatosis in NAFLD
    • COI: 1:STN:280:DC%2BC38ngtVGksg%3D%3D, PID: 22554256
    • Permutt Z, Le T, Peterson MR et al (2012) Correlation between liver histology and novel magnetic resonance imaging in adult patients with non-alcoholic fatty liver disease—MRI accurately quantifies hepatic steatosis in NAFLD. Aliment Pharmacol Ther 36(1):22–29
    • (2012) Aliment Pharmacol Ther , vol.36 , Issue.1 , pp. 22-29
    • Permutt, Z.1    Le, T.2    Peterson, M.R.3
  • 62
    • 84904763226 scopus 로고    scopus 로고
    • Serum cytokeratin-18 in the diagnosis of non-alcoholic steatohepatitis: a meta-analysis
    • Chen J, Zhu Y, Zheng Q, Jiang J (2013) Serum cytokeratin-18 in the diagnosis of non-alcoholic steatohepatitis: a meta-analysis. Hepatol Res. doi:10.1111/hepr.12197
    • (2013) Hepatol Res
    • Chen, J.1    Zhu, Y.2    Zheng, Q.3    Jiang, J.4
  • 63
    • 79956292596 scopus 로고    scopus 로고
    • Early detection of nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease by using MR elastography
    • PID: 21460032
    • Chen J, Talwalkar JA, Yin M, Glaser KJ, Sanderson SO, Ehman RL (2011) Early detection of nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease by using MR elastography. Radiology 259:749–756
    • (2011) Radiology , vol.259 , pp. 749-756
    • Chen, J.1    Talwalkar, J.A.2    Yin, M.3    Glaser, K.J.4    Sanderson, S.O.5    Ehman, R.L.6
  • 65
    • 19944427642 scopus 로고    scopus 로고
    • Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality
    • COI: 1:CAS:528:DC%2BD2MXjvFyqtbY%3D, PID: 15537682
    • Miller ER 3rd, Pastor-Barriuso R, Dalal D, Riemersma RA, Appel LJ, Guallar E (2005) Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality. Ann Intern Med 142:37–46
    • (2005) Ann Intern Med , vol.142 , pp. 37-46
    • Miller, E.R.1    Pastor-Barriuso, R.2    Dalal, D.3    Riemersma, R.A.4    Appel, L.J.5    Guallar, E.6
  • 66
    • 84866707482 scopus 로고    scopus 로고
    • Association between longer therapy with thiazolidinediones and risk of bladder cancer: a cohort study
    • COI: 1:CAS:528:DC%2BC38XhsVWgtb%2FJ, PID: 22878886
    • Mamtani R, Haynes K, Bilker WB et al (2012) Association between longer therapy with thiazolidinediones and risk of bladder cancer: a cohort study. J Natl Cancer Inst 104:1411–1421
    • (2012) J Natl Cancer Inst , vol.104 , pp. 1411-1421
    • Mamtani, R.1    Haynes, K.2    Bilker, W.B.3
  • 67
    • 84883223326 scopus 로고    scopus 로고
    • Comparing pioglitazone to insulin with respect to cancer, cardiovascular and bone fracture endpoints, using propensity score weights
    • COI: 1:CAS:528:DC%2BC3sXhvVSmu77M, PID: 23881565
    • Vallarino C, Perez A, Fusco G et al (2013) Comparing pioglitazone to insulin with respect to cancer, cardiovascular and bone fracture endpoints, using propensity score weights. Clin Drug Investig 33:621–631
    • (2013) Clin Drug Investig , vol.33 , pp. 621-631
    • Vallarino, C.1    Perez, A.2    Fusco, G.3
  • 68
    • 84896731000 scopus 로고    scopus 로고
    • Thiazolidinediones and cancer: results of a meta-analysis of randomized clinical trials
    • COI: 1:CAS:528:DC%2BC2cXislemsro%3D, PID: 23851465
    • Monami M, Dicembrini I, Mannucci E (2014) Thiazolidinediones and cancer: results of a meta-analysis of randomized clinical trials. Acta Diabetol 51:91–101
    • (2014) Acta Diabetol , vol.51 , pp. 91-101
    • Monami, M.1    Dicembrini, I.2    Mannucci, E.3
  • 69
    • 84880245463 scopus 로고    scopus 로고
    • Prevalence of nonalcoholic fatty liver disease in the United States: the Third National Health and Nutrition Examination Survey, 1988–1994
    • PID: 23703888
    • Lazo M, Hernaez R, Eberhardt MS et al (2013) Prevalence of nonalcoholic fatty liver disease in the United States: the Third National Health and Nutrition Examination Survey, 1988–1994. Am J Epidemiol 178:38–45
    • (2013) Am J Epidemiol , vol.178 , pp. 38-45
    • Lazo, M.1    Hernaez, R.2    Eberhardt, M.S.3
  • 70
    • 34247605492 scopus 로고    scopus 로고
    • Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients
    • PID: 17277038
    • Targher G, Bertolini L, Padovani R et al (2007) Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients. Diabetes Care 30:1212–1218
    • (2007) Diabetes Care , vol.30 , pp. 1212-1218
    • Targher, G.1    Bertolini, L.2    Padovani, R.3
  • 71
    • 0037129380 scopus 로고    scopus 로고
    • Nonalcoholic fatty liver disease
    • COI: 1:CAS:528:DC%2BD38XivVOmsrY%3D, PID: 11961152
    • Angulo P (2002) Nonalcoholic fatty liver disease. N Engl J Med 346:1221–1231
    • (2002) N Engl J Med , vol.346 , pp. 1221-1231
    • Angulo, P.1
  • 72
  • 73
    • 49649091383 scopus 로고    scopus 로고
    • Non-alcoholic fatty liver disease: an overview of prevalence, diagnosis, pathogenesis and treatment considerations
    • COI: 1:CAS:528:DC%2BD1cXpt1Sltrw%3D
    • Preiss D, Sattar N (2008) Non-alcoholic fatty liver disease: an overview of prevalence, diagnosis, pathogenesis and treatment considerations. Clin Sci (Lond) 115:141–150
    • (2008) Clin Sci (Lond) , vol.115 , pp. 141-150
    • Preiss, D.1    Sattar, N.2
  • 74
    • 78650486196 scopus 로고    scopus 로고
    • Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study
    • PID: 20858492
    • Williams CD, Stengel J, Asike MI et al (2011) Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study. Gastroenterology 140:124–131
    • (2011) Gastroenterology , vol.140 , pp. 124-131
    • Williams, C.D.1    Stengel, J.2    Asike, M.I.3
  • 75
    • 0025260531 scopus 로고
    • Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors
    • COI: 1:STN:280:DyaK3M%2FjtlGqsQ%3D%3D, PID: 2227807
    • Wanless IR, Lentz JS (1990) Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors. Hepatology 12:1106–1110
    • (1990) Hepatology , vol.12 , pp. 1106-1110
    • Wanless, I.R.1    Lentz, J.S.2
  • 76
    • 0024578117 scopus 로고
    • Liver pathology in diabetes mellitus and morbid obesity. Clinical, pathological, and biochemical considerations
    • PID: 2654841
    • Silverman JF, Pories WJ, Caro JF (1989) Liver pathology in diabetes mellitus and morbid obesity. Clinical, pathological, and biochemical considerations. Pathol Annu 24(Pt 1):275–302
    • (1989) Pathol Annu , vol.24 , pp. 275-302
    • Silverman, J.F.1    Pories, W.J.2    Caro, J.F.3
  • 77
    • 9044219843 scopus 로고    scopus 로고
    • Nonalcoholic steatohepatitis. Clinicopathological comparison with alcoholic hepatitis in ambulatory and hospitalized patients
    • COI: 1:STN:280:DyaK287mtVOmtg%3D%3D, PID: 8565753
    • Pinto HC, Baptista A, Camilo ME, Valente A, Saragoca A, de Moura MC (1996) Nonalcoholic steatohepatitis. Clinicopathological comparison with alcoholic hepatitis in ambulatory and hospitalized patients. Dig Dis Sci 41:172–179
    • (1996) Dig Dis Sci , vol.41 , pp. 172-179
    • Pinto, H.C.1    Baptista, A.2    Camilo, M.E.3    Valente, A.4    Saragoca, A.5    de Moura, M.C.6
  • 78
    • 85017799859 scopus 로고    scopus 로고
    • WGO global guidelines nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
    • World Gastroenterology Organisation (2012) WGO global guidelines nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. p 29
    • (2012) p 29
  • 79
    • 84859705556 scopus 로고    scopus 로고
    • Predictors for incidence and remission of NAFLD in the general population during a seven-year prospective follow-up
    • PID: 22245895
    • Zelber-Sagi S, Lotan R, Shlomai A et al (2012) Predictors for incidence and remission of NAFLD in the general population during a seven-year prospective follow-up. J Hepatol 56:1145–1151
    • (2012) J Hepatol , vol.56 , pp. 1145-1151
    • Zelber-Sagi, S.1    Lotan, R.2    Shlomai, A.3
  • 80
    • 0028875908 scopus 로고
    • The natural history of nonalcoholic fatty liver: a follow-up study
    • COI: 1:STN:280:DyaK28%2FovVyhtQ%3D%3D, PID: 7489979
    • Teli MR, James OF, Burt AD, Bennett MK, Day CP (1995) The natural history of nonalcoholic fatty liver: a follow-up study. Hepatology 22:1714–1719
    • (1995) Hepatology , vol.22 , pp. 1714-1719
    • Teli, M.R.1    James, O.F.2    Burt, A.D.3    Bennett, M.K.4    Day, C.P.5
  • 81
    • 77953971188 scopus 로고    scopus 로고
    • Disease progression of non-alcoholic fatty liver disease: a prospective study with paired liver biopsies at 3 years
    • PID: 20581244
    • Wong VW, Wong GL, Choi PC et al (2010) Disease progression of non-alcoholic fatty liver disease: a prospective study with paired liver biopsies at 3 years. Gut 59:969–974
    • (2010) Gut , vol.59 , pp. 969-974
    • Wong, V.W.1    Wong, G.L.2    Choi, P.C.3
  • 82
    • 58849134985 scopus 로고    scopus 로고
    • Long-term follow-up of patients with nonalcoholic fatty liver
    • PID: 19049831
    • Rafiq N, Bai C, Fang Y et al (2009) Long-term follow-up of patients with nonalcoholic fatty liver. Clin Gastroenterol Hepatol 7:234–238
    • (2009) Clin Gastroenterol Hepatol , vol.7 , pp. 234-238
    • Rafiq, N.1    Bai, C.2    Fang, Y.3
  • 83
    • 4644297019 scopus 로고    scopus 로고
    • Natural history of nonalcoholic steatohepatitis: a longitudinal study of repeat liver biopsies
    • PID: 15382171
    • Fassio E, Alvarez E, Dominguez N, Landeira G, Longo C (2004) Natural history of nonalcoholic steatohepatitis: a longitudinal study of repeat liver biopsies. Hepatology 40:820–826
    • (2004) Hepatology , vol.40 , pp. 820-826
    • Fassio, E.1    Alvarez, E.2    Dominguez, N.3    Landeira, G.4    Longo, C.5
  • 84
    • 14644392822 scopus 로고    scopus 로고
    • Histological progression of non-alcoholic fatty liver disease in Chinese patients
    • COI: 1:STN:280:DC%2BD2M%2FotVKmsw%3D%3D, PID: 15709991
    • Hui AY, Wong VW, Chan HL et al (2005) Histological progression of non-alcoholic fatty liver disease in Chinese patients. Aliment Pharmacol Ther 21:407–413
    • (2005) Aliment Pharmacol Ther , vol.21 , pp. 407-413
    • Hui, A.Y.1    Wong, V.W.2    Chan, H.L.3
  • 85
    • 79960549297 scopus 로고    scopus 로고
    • The natural history of nonalcoholic fatty liver disease with advanced fibrosis or cirrhosis: an international collaborative study
    • PID: 21688282
    • Bhala N, Angulo P, van der Poorten D et al (2011) The natural history of nonalcoholic fatty liver disease with advanced fibrosis or cirrhosis: an international collaborative study. Hepatology 54:1208–1216
    • (2011) Hepatology , vol.54 , pp. 1208-1216
    • Bhala, N.1    Angulo, P.2    van der Poorten, D.3
  • 86
    • 0043268063 scopus 로고    scopus 로고
    • Long-term outcomes of cirrhosis in nonalcoholic steatohepatitis compared with hepatitis C
    • PID: 12883486
    • Hui JM, Kench JG, Chitturi S et al (2003) Long-term outcomes of cirrhosis in nonalcoholic steatohepatitis compared with hepatitis C. Hepatology 38:420–427
    • (2003) Hepatology , vol.38 , pp. 420-427
    • Hui, J.M.1    Kench, J.G.2    Chitturi, S.3
  • 87
    • 33645963121 scopus 로고    scopus 로고
    • Similarities and differences in outcomes of cirrhosis due to nonalcoholic steatohepatitis and hepatitis C
    • PID: 16502396
    • Sanyal AJ, Banas C, Sargeant C et al (2006) Similarities and differences in outcomes of cirrhosis due to nonalcoholic steatohepatitis and hepatitis C. Hepatology 43:682–689
    • (2006) Hepatology , vol.43 , pp. 682-689
    • Sanyal, A.J.1    Banas, C.2    Sargeant, C.3
  • 88
    • 75449088414 scopus 로고    scopus 로고
    • Decreased survival of subjects with elevated liver function tests during a 28-year follow-up
    • PID: 20014114
    • Soderberg C, Stal P, Askling J et al (2010) Decreased survival of subjects with elevated liver function tests during a 28-year follow-up. Hepatology 51:595–602
    • (2010) Hepatology , vol.51 , pp. 595-602
    • Soderberg, C.1    Stal, P.2    Askling, J.3
  • 89
    • 4344628555 scopus 로고    scopus 로고
    • The clinical features, diagnosis and natural history of nonalcoholic fatty liver disease. Clin Liver Dis 8:521–533
    • McCullough AJ (2004) The clinical features, diagnosis and natural history of nonalcoholic fatty liver disease. Clin Liver Dis 8:521–533, viii
    • (2004) viii
    • McCullough, A.J.1
  • 90
    • 16244369103 scopus 로고    scopus 로고
    • Prognosis of hepatocellular carcinoma: comparison of 7 staging systems in an American cohort
    • PID: 15795889
    • Marrero JA, Fontana RJ, Barrat A et al (2005) Prognosis of hepatocellular carcinoma: comparison of 7 staging systems in an American cohort. Hepatology 41:707–716
    • (2005) Hepatology , vol.41 , pp. 707-716
    • Marrero, J.A.1    Fontana, R.J.2    Barrat, A.3
  • 91
    • 63049133092 scopus 로고    scopus 로고
    • Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005
    • PID: 19224838
    • Altekruse SF, McGlynn KA, Reichman ME (2009) Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005. J Clin Oncol 27:1485–1491
    • (2009) J Clin Oncol , vol.27 , pp. 1485-1491
    • Altekruse, S.F.1    McGlynn, K.A.2    Reichman, M.E.3
  • 92
    • 20344374757 scopus 로고    scopus 로고
    • Survival rate in patients with hepatocellular carcinoma: a retrospective analysis of 389 patients
    • COI: 1:STN:280:DC%2BD2M3lvVaqtw%3D%3D, PID: 15870713
    • Greten TF, Papendorf F, Bleck JS et al (2005) Survival rate in patients with hepatocellular carcinoma: a retrospective analysis of 389 patients. Br J Cancer 92:1862–1868
    • (2005) Br J Cancer , vol.92 , pp. 1862-1868
    • Greten, T.F.1    Papendorf, F.2    Bleck, J.S.3
  • 93
    • 34347339562 scopus 로고    scopus 로고
    • Survival and recurrence rates after resection for hepatocellular carcinoma in noncirrhotic livers
    • PID: 17617329
    • Lang H, Sotiropoulos GC, Brokalaki EI et al (2007) Survival and recurrence rates after resection for hepatocellular carcinoma in noncirrhotic livers. J Am Coll Surg 205:27–36
    • (2007) J Am Coll Surg , vol.205 , pp. 27-36
    • Lang, H.1    Sotiropoulos, G.C.2    Brokalaki, E.I.3
  • 94
    • 35148887206 scopus 로고    scopus 로고
    • Outcome of patients with hepatocellular carcinoma referred to a tertiary centre with availability of multiple treatment options including cadaveric liver transplantation
    • PID: 17919236
    • Perry JF, Charlton B, Koorey DJ et al (2007) Outcome of patients with hepatocellular carcinoma referred to a tertiary centre with availability of multiple treatment options including cadaveric liver transplantation. Liver Int 27:1240–1248
    • (2007) Liver Int , vol.27 , pp. 1240-1248
    • Perry, J.F.1    Charlton, B.2    Koorey, D.J.3
  • 95
    • 70350046669 scopus 로고    scopus 로고
    • Cytokeratin-18 fragment levels as noninvasive biomarkers for nonalcoholic steatohepatitis: a multicenter validation study
    • COI: 1:CAS:528:DC%2BD1MXhtlWlu7jL, PID: 19585618
    • Feldstein AE, Wieckowska A, Lopez AR, Liu YC, Zein NN, McCullough AJ (2009) Cytokeratin-18 fragment levels as noninvasive biomarkers for nonalcoholic steatohepatitis: a multicenter validation study. Hepatology 50:1072–1078
    • (2009) Hepatology , vol.50 , pp. 1072-1078
    • Feldstein, A.E.1    Wieckowska, A.2    Lopez, A.R.3    Liu, Y.C.4    Zein, N.N.5    McCullough, A.J.6
  • 96
    • 34247384560 scopus 로고    scopus 로고
    • The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD
    • COI: 1:CAS:528:DC%2BD2sXltlWis7k%3D, PID: 17393509
    • Angulo P, Hui JM, Marchesini G et al (2007) The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD. Hepatology 45:846–854
    • (2007) Hepatology , vol.45 , pp. 846-854
    • Angulo, P.1    Hui, J.M.2    Marchesini, G.3
  • 97
    • 41349094999 scopus 로고    scopus 로고
    • Performance of transient elastography for the staging of liver fibrosis: a meta-analysis
    • PID: 18395077
    • Friedrich-Rust M, Ong MF, Martens S et al (2008) Performance of transient elastography for the staging of liver fibrosis: a meta-analysis. Gastroenterology 134:960–974
    • (2008) Gastroenterology , vol.134 , pp. 960-974
    • Friedrich-Rust, M.1    Ong, M.F.2    Martens, S.3
  • 98
    • 84891889855 scopus 로고    scopus 로고
    • Systematic review with meta-analysis: non-invasive assessment of non-alcoholic fatty liver disease—the role of transient elastography and plasma cytokeratin-18 fragments
    • COI: 1:STN:280:DC%2BC2c3jslKhtw%3D%3D, PID: 24308774
    • Kwok R, Tse YK, Wong GL et al (2014) Systematic review with meta-analysis: non-invasive assessment of non-alcoholic fatty liver disease—the role of transient elastography and plasma cytokeratin-18 fragments. Aliment Pharmacol Ther 39:254–269
    • (2014) Aliment Pharmacol Ther , vol.39 , pp. 254-269
    • Kwok, R.1    Tse, Y.K.2    Wong, G.L.3
  • 99
    • 84855835833 scopus 로고    scopus 로고
    • Performance of Acoustic Radiation Force Impulse imaging for the staging of liver fibrosis: a pooled meta-analysis
    • COI: 1:STN:280:DC%2BC383jtlymtA%3D%3D, PID: 22239521
    • Friedrich-Rust M, Nierhoff J, Lupsor M et al (2012) Performance of Acoustic Radiation Force Impulse imaging for the staging of liver fibrosis: a pooled meta-analysis. J Viral Hepat 19:e212–e219
    • (2012) J Viral Hepat , vol.19 , pp. e212-e219
    • Friedrich-Rust, M.1    Nierhoff, J.2    Lupsor, M.3
  • 100
    • 84885959250 scopus 로고    scopus 로고
    • The efficiency of acoustic radiation force impulse imaging for the staging of liver fibrosis: a meta-analysis
    • PID: 23801420
    • Nierhoff J, Chavez Ortiz AA, Herrmann E, Zeuzem S, Friedrich-Rust M (2013) The efficiency of acoustic radiation force impulse imaging for the staging of liver fibrosis: a meta-analysis. Eur Radiol 23:3040–3053
    • (2013) Eur Radiol , vol.23 , pp. 3040-3053
    • Nierhoff, J.1    Chavez Ortiz, A.A.2    Herrmann, E.3    Zeuzem, S.4    Friedrich-Rust, M.5
  • 101
    • 77950619459 scopus 로고    scopus 로고
    • Pitfalls of liver stiffness measurement: a 5-year prospective study of 13,369 examinations
    • PID: 20063276
    • Castera L, Foucher J, Bernard PH et al (2010) Pitfalls of liver stiffness measurement: a 5-year prospective study of 13,369 examinations. Hepatology 51:828–835
    • (2010) Hepatology , vol.51 , pp. 828-835
    • Castera, L.1    Foucher, J.2    Bernard, P.H.3
  • 102
    • 33750120876 scopus 로고    scopus 로고
    • Transient elastography (FibroScan) for non-invasive assessment of liver fibrosis
    • Murtagh J, Foerster V (2006) Transient elastography (FibroScan) for non-invasive assessment of liver fibrosis. Issues Emerg Health Technol 1–4
    • (2006) Issues Emerg Health Technol , pp. 1-4
    • Murtagh, J.1    Foerster, V.2
  • 103
    • 65949094613 scopus 로고    scopus 로고
    • An evaluation of the potential cost-effectiveness of non-invasive testing strategies in the diagnosis of significant liver fibrosis
    • PID: 19457153
    • Carlson JJ, Kowdley KV, Sullivan SD, Ramsey SD, Veenstra DL (2009) An evaluation of the potential cost-effectiveness of non-invasive testing strategies in the diagnosis of significant liver fibrosis. J Gastroenterol Hepatol 24:786–791
    • (2009) J Gastroenterol Hepatol , vol.24 , pp. 786-791
    • Carlson, J.J.1    Kowdley, K.V.2    Sullivan, S.D.3    Ramsey, S.D.4    Veenstra, D.L.5
  • 105
    • 42149189962 scopus 로고    scopus 로고
    • Utilization rates, complications and costs of percutaneous liver biopsy: a population-based study including 4275 biopsies
    • PID: 18433397
    • Myers RP, Fong A, Shaheen AA (2008) Utilization rates, complications and costs of percutaneous liver biopsy: a population-based study including 4275 biopsies. Liver Int 28:705–712
    • (2008) Liver Int , vol.28 , pp. 705-712
    • Myers, R.P.1    Fong, A.2    Shaheen, A.A.3
  • 106
    • 84943361716 scopus 로고    scopus 로고
    • Régie de l'assurance maladie du Québec (RAMQ). RAMQ liste de medicaments 2013. Quebec Ministry of Health and Social Services; 2013. Accessed Aug 2013
    • Régie de l'assurance maladie du Québec (RAMQ). RAMQ liste de medicaments 2013. Quebec Ministry of Health and Social Services; 2013. Available at https://www.prod.ramq.gouv.qc.ca/DPI/PO/Commun/PDF/Liste_Med/Liste_Med/liste_med_cor_2013_07_15_fr.pdf. Accessed Aug 2013
  • 107
    • 41649118950 scopus 로고    scopus 로고
    • Surveillance of cirrhosis for hepatocellular carcinoma: a cost-utility analysis
    • COI: 1:STN:280:DC%2BD1c3itl2jtw%3D%3D, PID: 18382459
    • Thompson Coon J, Rogers G, Hewson P et al (2008) Surveillance of cirrhosis for hepatocellular carcinoma: a cost-utility analysis. Br J Cancer 98:1166–1175
    • (2008) Br J Cancer , vol.98 , pp. 1166-1175
    • Thompson Coon, J.1    Rogers, G.2    Hewson, P.3
  • 108
    • 82955197321 scopus 로고    scopus 로고
    • Cost of a quality-adjusted life year in liver transplantation: the influence of the indication and the model for end-stage liver disease score
    • PID: 21770017
    • Aberg F, Maklin S, Rasanen P et al (2011) Cost of a quality-adjusted life year in liver transplantation: the influence of the indication and the model for end-stage liver disease score. Liver Transpl 17:1333–1343
    • (2011) Liver Transpl , vol.17 , pp. 1333-1343
    • Aberg, F.1    Maklin, S.2    Rasanen, P.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.